PERSONAL CHARACTERISTICS OF PATIENTS WITH DEPRESSIVE DISORDERS
Abstract
The aim of this paper is to study the features of the personal characteristics of patients with depressive disorders at the present stage, taking into account gender and age factors. Clinically examined 107 men and 138 women with depressive disorders (ICD-10 codes F31.3, F31.4, F32.0, F32.1, F32.2, F33.0, F33.1, F33.2) using Mini-mult test. Persistent pathocharacterological changes were revealed in patients with depressive disorders, the basis of these transformations are persistent depressive manifestations in combination with a high level of anxiety, asthenia and hypochondriasis, as well as moderate manifestations of hysteria, psychopathy, paranoia and schizoidism. In men, more pronounced manifestations of depression, paranoia and schizoidism were revealed, and in women – psychasthenia, hypochondriasis and psychopathic manifestations. The manifestations of depression, hypochondriasis, psychopathy, paranoia and schizoidness, which are least pronounced in the young age group (up to 30 years old), and most pronounced in the older age group (45 years and older). The manifestations of psychasthenia are minimal in the younger age group, reach the highest level in the middle age group (30-44 years old), and slightly decrease in the older age group.
References
2. Belov O.O., Pshuk N.G. (2019). Some trends of clinical and symptomatic pathomorphosis of depressive disorders taking into account the age factor. Wiadomości Lekarskie, 72(9), 1786-1790.
3. Cleare А., Pariante C.M., Young A.H. (2015). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 29(5), 459–525.
4. Fekadu N., Shibeshi W., Engidawork E. (2017). Major depressive disorder: pathophysiology and clinical management. Journal of Depression and Anxiety, 6(1), 255–257.
5. Klein D.N., Kotov R., Bufferd S.J. (2011). Personality and Depression: Explanatory Models and Review of the Evidence. Annu Rev Clin Psychol, 7, 269–295.
6. Kraus C., Kadriu B., Lanzenberger R., Zarate C.A., Kasper S. (2019). Prognosis and improved outcomes in major depression: a review. Translational Psychiatry, 9, 127.
7. Limandri B.J. (2018). Treatment-Resistant Depression: Identification and Treatment Strategies. Journal of Psychosocial Nursing and Mental Health Services, 56(9), 11-15.
8. Malhi G.S., Mann J.J. (2018). Depression. Lancet, 24(10161), 2299-2312.
9. Markova M., Rezunenko O., Kozhyna H. (2017). Contents and efficiency measures of psychoeducation in rehabilitation system of patients with bipolar affective disorder. Journal of Education, Health end Sport formerly Journal of Health Sciences, 7, 711–715.
10. McLachlan G. (2018). Treatment resistant depression: what are the options? BMJ, 363, k5354.
11. Ogbo F.A., Mathsyaraja S., Koti R.K., Perz J. (2018) Page A. The burden of depressive disorders in South Asia, 1990–2016: findings from the global burden of disease study. BMC Psychiatry, 18, 333.
12. Pshuk N.G., Stukan L.V., Kaminska A.O. (2018). Introducing system of psychotherapeutic intervention for family caregivers of patients with endogenous mental disorders. Wiadomosci Lekarskie, 71(5), 980-985.
13. Wiles N., Taylor A., Turner N., Barnes M., Campbell J., Lewis G., Morrison J., Peters T.J., Thomas L., Turner K., Kessler D. (2018). Management of treatment-resistant depression in primary care: a mixed-methods study. British Journal of General Practice, 68(675), e673–e681.
14. Zaytsev V.P. (1981). Variant psihologicheskogo testa Mini-Mult [Variant of Psychological test Mini-Mult]. Psychological Journal. 3. 118-123.
15. Zuckerman H., Pan Z., Park C., Brietzke E., Musial N., Shariq A.S., Iacobucci M., Yim S.J., Lui L.M.W., Rong C., McIntyre R.S. (2018). Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder. Frontiers in Psychiatry, 9, 655.
Abstract views: 371 PDF Downloads: 130
